From: Comparison of score-based prediction of 90-day mortality after liver resection
Characteristics | Total Cohort (n = 529) | 90-day Mortality (n = 24, 4.54%) | P-Value | ||
---|---|---|---|---|---|
Demographics | n | % | n | % | |
Age (median; IQR) | 61.8 | (52.8–69.0) | 69.3 | (62.1–74.9) | 0.0049 |
Male: Female | 323:206 | 61.1%:38.9% | 20:4 | 83.3%:16.7% | 0.0301 |
Preoperative risk | |||||
Diabetes mellitus | 93 | 17.6% | 8 | 33.3% | 0.0516 |
Cardiac disease | 102 | 19.3% | 8 | 33.3% | 0.1064 |
Renal disease | 33 | 6.2% | 2 | 8.3% | 0.6557 |
Pulmonary disease | 47 | 8.9% | 1 | 4.2% | 0.7125 |
ASA III,IV | 243 | 45.9% | 14 | 58.3% | 0.2945 |
BMI ≥ 30 kg/m2a | 98 | 18.8% | 3 | 13.0% | 0.5939 |
Tumour entity | |||||
Intrahepatic cholangiocarcinoma | 59 | 11.2% | 2 | 8.3% | 1.0 |
Perihilar cholangiocarcinoma | 35 | 6.6% | 8 | 33.3% | < 0.0001 |
Surgical procedure | |||||
Right trisectionectomy | 39 | 7.4% | 10 | 41.7% | < 0.0001 |
Preoperative lab values | |||||
INR ≥ 1.1 | 61 | 11.5% | 6 | 25.0% | 0.0466 |
GGT ≥ 60 U/l | 285 | 53.9% | 22 | 91.7% | < 0.0001 |
Thrombocytes < 120/nl | 32 | 6.0% | 4 | 16.7% | 0.0497 |
Creatinine≥2 mg/dl | 7 | 1.3% | 1 | 4.2% | 0.2789 |
Total Bilirubin≥2 mg/dl | 33 | 6.2% | 7 | 29.2% | 0.0003 |